Skip to main content
. 2017 Aug 8;12(8):e0182208. doi: 10.1371/journal.pone.0182208

Fig 3. The prognostic value of ALDH1A1/B1/L1 mRNA expression in HBV-related HCC patients [data from the GEO database (accession: GSE14520)].

Fig 3

A and C: The Kaplan–Meier survival analyses of aldehyde dehydrogenase (ALDH)1B1 and ALDH1L1 expression of the overall survival time of HBV-related HCC patients. B and D: The Kaplan–Meier survival analyses of ALDH1B1 and ALDH1L1 expression in recurrence–free survival time of HBV-related HCC patients. E and F: The Kaplan–Meier survival analyses of ALDH1A1 expression in recurrence–free survival time and 57–month recurrence–free survival time of HBV related HCC patients, respectively. HCC = hepatocellular carcinoma.